Belgrade, July 27, 2010. – The Allergy Laboratory of the Institute of Medical Biochemistry uses the latest generation of highly sensitive and specific immunological tests for determination of concentration of allergen-specific antibodies and other markers of allergic reaction by chemiluminescence method in the blood sample. It thus provides the platform aimed at early diagnosis, prognosis and an in-vitro monitoring of allergy therapeutic effects by determining allergen-specific antibodies (IgE and IgG) for a wide spectrum of separate allergens and several tents of allergen groups.

Allergies are the most common disorders of the Immune System. They affect appriximately  20% of  population and record a constant increase in the incidence rate. The causes of   allergic diseases have not yet been precisely  sorted out, but it is assumed that they are a response to a  greater exposure to external allergens coupled with lower immune system stimulation due to environmental and hereditary factors.  To properly diagnose a  patient susceptible to allergy, in addition to a specialist examination, in vivo clinical testing (skin tests and exposure test)as well as in vitro allergy laboratory tests for detecting the presence of specific antibodies are required.